AlphAIAlphAI — Financial news for AI agents
SEC EDGARSEP 221 min read$CTEV

Garis Douglas Michael sold $276K of CTEV

Garis Douglas Michael (EVP&CFO) sold 9,025 shares of Claritev Corp (CTEV) at an average of $30.59 ($30.50–$31.19, $0.28M total) across 2 trades on 2026-09-21 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Garis Douglas Michael
Published Sep 22, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 8:48 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$CTEV
Neutral
medium confidence
Mentioned
$CTEV
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CTEVNeutralLow
01

Why it matters

The disclosed sale is modest and executed under a pre‑arranged 10b5‑1 plan, suggesting limited informational content.

02

Market read

Small insider sale; unlikely to move the stock significantly.

03

What to watch

If the insider holds a large post‑sale stake, the impact is further muted.

Relevance 3/10Novelty 4/10Timing: post‑market 2026-09-21

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$CTEVNeutralMedium confidence
Context

EVP&CFO Garis Douglas Michael sold 9,025 shares for $276K via a 10b5-1 plan on 2026-09-21.

Expected impact

Potential short-term pressure, likely limited impact.

Evidence & confidence

Sale amount is small; market may view as routine execution of pre‑arranged plan.

Market effects

Sector

Minimal effect on the broader biotech/health‑tech sector.

Regional

None

Global

None

Counterpoint

What could challenge this read

Sale could be purely mechanical; investors may ignore.

Key entities

  • Company
    Claritev Corp

    Issuer of the securities sold.

  • Insider
    Garis Douglas Michael

    EVP&CFO of Claritev Corp.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

CTEV insider trading history →

Related articles

AUG 9
$CTEVMedAI 8/10

Claritev Q2 Earnings Call Highlights

Claritev (NYSE:CTEV) reported Q2 No Surprises Act-related revenue growth attributed mainly to one client, with management saying claim mix drove lower charges per claim. Bookings were $30M ACV in Q2 and $74M in H1, exceeding 2025 total and targeting over $100M for FY. FY revenue guidance raised to $1.00B-$1.02B and adjusted EBITDA to $610M-$620M.

yahoo.com5 min
AUG 7
$CTEVMed

Claritev Corp (CTEV): Results of Operations and Financial Condition

Claritev Corp (CTEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Claritev Corporation Reports Second Quarter 2026 Results – Q2 2026 Revenues of $257.5 million grew 6.6% compared to Q2 2025 – Net Loss of $59.2 million – Adjusted EBITDA of $155.8 million increased 1.1% compared to Q2 2025 (Adjusted EBITDA Margin of 60.5% versus 63.8% in Q2 202

SEC EDGAR 8-K6 min